Develops antibodies for inflammatory bowel diseases.
Jun 2026Revenue $1.00M/yrExpenses $56.8M/yr
No trendCash runway ≈ 1.5 years from Jun 2026
Figures by year
When will Shattuck Labs be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $1.00M and expenses $56.8M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.00M | $52.5M | −$51.5M |
| Dec 2024 | $5.72M | $86.3M | −$80.6M |
| Dec 2023 | $1.66M | $93.6M | −$92.0M |
| Dec 2022 | $652K | $104M | −$103M |
| Dec 2021 | $30.0M | $75.3M | −$45.3M |
| Dec 2020 | $9.93M | $46.9M | −$36.9M |
| Dec 2019 | $9.89M | $35.0M | −$25.1M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.